Tidemark, LLC Charles River Laboratories International, Inc. Transaction History
Tidemark, LLC
- $253 Million
- Q4 2024
A detailed history of Tidemark, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Tidemark, LLC holds 25 shares of CRL stock, worth $3,799. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25
Previous 25
-0.0%
Holding current value
$3,799
Previous $4,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
703Shares Held
52.8MCall Options Held
157KPut Options Held
413K-
Vanguard Group Inc Valley Forge, PA6.16MShares$936 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$773 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$620 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$332 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$275 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.73B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...